TCTR20211229003招募中4 期
Switching to Dolutegravir bases regimens vs Rilpivirine based regimens in antiretroviral experienced patients with virological supression: randomized controlled trial, open label
/A0 个研究点目标入组 210 人开始时间: 2021年12月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Patients more than 18 years of age who have previously received antiretroviral regimens Tenofovir/Emtricitabine/Efavirenz for more than or equal to 6 months and have an HIV-1 RNA viral load of less than 20 copies/ml within 6 months before the study.
排除标准
- •1. Infected with HIV 2 RNA, 2. Evidence that one of the antiretroviral drug resistance genes is found, 3. Drug interactions such as proton pump inhibitors, H2 receptor antagonists, rifampicin, and anticonvulsants, 4. Being pregnant or breastfeeding, 5. The renal function calculated from the Cockcroft Gault equation is less than 60 mL/min, 6. Have a psychiatric illness
研究者
相似试验
进行中（未招募）
1 期
Comparison between a Raltegravir-based treatment versus a raltegravir-based treatment plus atorvastatin for reducing aging-related inflamation in HIV-infected patients older than 60 years.EUCTR2015-002682-30-ESFundació Lluita contra la SIDA60
进行中（未招募）
1 期
THE EFFECTS OF SWITCHING FROM DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR (D/L/A) TO BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (B/F/TAF) IN PATIENTS WITH SUPPRESSED VIRAL LOAD ON NEUROPSYCHIATRIC SIDE EFFECTS AND NEUROCOGNITIVE FUNCTIOHIV-1 infectionMedDRA version: 20.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2018-004885-32-ITAZIENDA OSPEDALIERA UNIVERSITARIA SENESE100
撤回
2 期
Dolutegravir + Rilpivirine Switch Study (DORISS)HIV InfectionHAART-treatedVirologically ControlledNCT02069834Nantes University Hospital
Unknown
不适用
DoRa studiePEP, HIVNL-OMON26416niversity Medical Centrum Utrecht200
Unknown
3 期
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based RegimenHIV-1-infectionNCT04155554Azienda Ospedaliera Universitaria Senese100